Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial
- Fizazi, K.
- González Mella, P.
- Castellano, D.
- Minatta, J.N.
- Rezazadeh Kalebasty, A.
- Shaffer, D.
- Vázquez Limón, J.C.
- Sánchez López, H.M.
- Armstrong, A.J.
- Horvath, L.
- Bastos, D.A.
- Amin, N.P.
- Li, J.
- Unsal-Kacmaz, K.
- Retz, M.
- Saad, F.
- Petrylak, D.P.
- Pachynski, R.K.
ISSN: 1879-0852, 0959-8049
Ano de publicación: 2022
Volume: 160
Páxinas: 61-71
Tipo: Artigo